The 5th Edition of the India Biopharma Leaders Conclave has the theme "New Horizons in Biopharma, Biosimilars, & Biologics." This theme likely indicates a focus on exploring new frontiers and opportunities in the biopharmaceutical industry, particularly in the areas of biosimilars and biologics. The conclave may feature discussions and presentations on advancements in biopharmaceutical R&D regulatory updates, market trends, and the latest innovations in the development and manufacturing of biosimilar and biologic products. It could also address challenges and opportunities in these sectors, such as improving access to affordable biopharmaceuticals and ensuring quality and safety standards.
Join us with renowned speakers and eminent leaders from around the world for the conference as we exaggerate the present to imagine a future where biopharma isn't just a field of study but a journey of discovery that holds the promise of transforming millions of lives.
☑️ Gain valuable insights into the evolving landscape of the biopharma industry, including the impact of innovations, regulatory changes, and compliance challenges
☑️ Emphasize the opportunities for making connections with industry peers, potential collaborators to expand your professional network.
☑️ Discover new products, services, and technologies that are driving innovation in the biopharma sector.
☑️ Participate in a forum that encourages the exchange of knowledge and ideas, fostering collaborations that could shape the trajectory of the industry.
☑️ Discuss the challenges faced by the biopharma industry, including regulatory hurdles, research and development complexities, market competition, and ethical considerations.
Mr. K.Raja Bhanu,
Director General, PHARMEXCIL
Dr. Tathagata Dutta,
Chief Scientific Officer (CSO),
Refex Life Sciences
Dr Subhash Thuluva,
Senior VP & Head- Clinical Development, Biological E Limited
Dr. Ranjan Chakrabrati,
Consultant, R&D Strategy, Biologics, Drug Discovery, Biopharma Consultant
Dr Balasubramanya S
General Manager, Association for Biotech-led Enterprises (ABLE)
Dr. Ashok Kumar Patra,
Director, Biologics Development,
Imgenex India Pvt. Ltd
Dr. Annu Uppal,
Director Scientific Affairs,
US Pharmacopeia
Dr. Shubhadeep Sinha,
Senior VP Medical Director & Head Clinical Development /Medical Affairs, Hetero Group
Dr. Kishore J.R. Kunapuli,
Chief Scientific Officer- Cell Therapy Division,
Pulse Pharmaceuticals Pvt. Ltd
Dr. Arun Shastry,
Chief Scientific Officer,
Hanugen Therapeutics
Dr. Murali K Addepalli PhD,
Chief Scientific Officer
Lextro Bio
Mr. Mannan Khambati,
VP Biotech Production, Bharat Serums and Vaccines Limited
Mr. Jaganmohan Reddy
Founder, CEO & CSO
UR Advanced Therapeutics Pvt Ltd
Mr. Mukesh Patale
Head of USP MSAT (Group Lead), Dr. Reddy’s Laboratory, Biologics division
Dr. Anurag Tiwari,
AVP, R&D,
Zumutor Biologics Pvt. Ltd.
Dr. Arindam Saha Ph.D.
Project Group Leader
Biocon Biologics
Dr. Rajendra Lingala
Chief Technology Officer - Biotechnology
Biophore India Pharmaceuticals Pvt. Ltd.
Dr. Manish Mahajan MD,
General Manager, Zydus Group Lifesciences
Dr. Arun Anand,
Independent CGT Industry expert, and Ex-COO/ Board Director, Immuneel Therapeutics Pvt. Ltd.
Dr. Sridhar Yeshamaina,
Vice President, Global Patient Safety and Clinical Affairs,
Amneal Pharmaceuticals
Mr. Rajesh Kumar Chopra,
President – Operations, Site Head-Manufacturing Excellence,
Ichor Biologics Pvt. Ltd.
Mr. Dhiraj Nagendra,
General Manager Quality Assurance,
Ichor Biologicals
Ms. Rajni Jha,
Independent Director,
IOL Chemicals & Pharmaceuticals Ltd.
Dr. Anup Choudhury,
Medical Director, Global clinical development, Novartis
Dr. Swagatam Ray, Ph.D, General Manager, Cell and Gene Therapy, Intas Pharmaceuticals Ltd.
Dr. G.V.J.A.Harshavardhan, Director General, Indian Vaccine Manufacturers Association IVMA
Mr. Daya Thota, Head Quality Assurance - Biologics Division, MSN Laboratories Pvt. Ltd.
Dr. Edward Wong,
Senior Manager of Gene Writing and Editing, APAC (Integrated DNA Technologies, Danaher)
Dr. Shuvankar Ballav,
Regulatory Affairs,
Ipca Laboratories Limited
Mr. Siva Sankar Mahamkali,
Director,
Aragen Life sciences pvt Ltd
Mr. Satish Makkina,
Head,
Procell Biologics Pvt Ltd
Ms. Lakshmi Prasanna,
Senior Director, Pharmexcil
Mr. C S Mujeebuddin,
Founder & CEO,
Clinosol Research Private Limited
Dr Dipankar Das, PhD,
Director and Head-Biologics,
USP India
Mr. Vamsi Krishna Tata,
Senior Manager,
Global Regulatory Affairs
Dr.Balakota Reddy P
CTO,
Loka Biosciences Pvt Ltd
Ms. Sonia Gandhi
DGM & Head, Regulatory Affairs and Policy Advocacy division BIRAC, DBT
Dr. Poonam Deep
BDS, MBA, Director Genetix Biotech Asia Ltd
Ms. Srushti Sanghavi Shah
CEO, Nanghavi
Dr. Vasundhra Bhandari
PhD (Biological Sciences),
Faculty Incharge (Department of Pharmacoinformatics and Biopharmaceuticals),
Biological Sciences
Ms. Rupa Vangala,
Technology Consultant & Former Director - Engineering & Intelligent Automation Bristol Myers Squibb
BlueTech Media LLP
10th floor, North Wing WeWork, BLDG NO.4, Nesco IT PARK, Western Express Highway, Goregaon East, MUMBAI 400063
Copyright © 2025 BlueTech Media LLP - All Rights Reserved.
Designed by Whyte Wings Media
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.